Pharma Leaders Valencia Technologies Secures Strategic Investment of $35 Million from Brooks Advisory Group, Appoints James D. Surek as CEO 2 months ago
Pharma Leaders Biogen, Stoke Therapeutics Ink Deal to Develop Zorevunersen for Dravet Syndrome 2 months ago
Pharma Leaders Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more 2 months ago
Pharma Leaders Genentech, Novartis, and FARE Partner for Food Allergy Educational Campaign 2 months ago